b-D-Glucopyranosiduronic acid,(3R,5S)-1-methyl-2-oxo-5-(3-pyridinyl)-3-pyrrolidinyl (132929-88-5)

Identification
Name:	b-D-Glucopyranosiduronic acid,(3R,5S)-1-methyl-2-oxo-5-(3-pyridinyl)-3-pyrrolidinyl
Synonyms:	b-D-Glucopyranosiduronic acid,1-methyl-2-oxo-5-(3-pyridinyl)-3-pyrrolidinyl, (3R-trans)-;trans-3'-Hydroxycotinine-O-glucuronide
CAS:	132929-88-5
Molecular Formula:	C16H20 N2 O8
Molecular Weight:	368.34
InChI:	InChI=1/C16H20N2O8/c1-18-8(7-3-2-4-17-6-7)5-9(14(18)22)25-16-12(21)10(19)11(20)13(26-16)15(23)24/h2-4,6,8-13,16,19-21H,5H2,1H3,(H,23,24)/t8-,9+,10-,11-,12+,13-,16+/m0/s1
Molecular Structure:
Properties
Flash Point:	376.7°C
Boiling Point:	699.2°Cat760mmHg
Density:	1.58g/cm³
Refractive index:	1.652
Flash Point:	376.7°C
Usage:	A nicotine metabolite
Safety Data

Other Product

b-D-Glucopyranosiduronic acid,4-(methylnitrosoamino)-1-(3-pyridinyl)butyl
b-D-Glucopyranosiduronic acid,7-chloro-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl
Butanoic acid,4-oxo-4-[[6-[(5S)-2-oxo-5-(3-pyridinyl)-1-pyrrolidinyl]hexyl]amino]-
b-D-Glucopyranosiduronic acid,4-[[3-[[[4-(3-amino-3-carboxypropoxy)phenyl]hydroxyacetyl]amino]-3-(formylamino)-2-oxo-1-azetidinyl]carboxymethyl]phenyl,sodium salt, [3S-[1(S*),3R*[S*(S)]]]- (9CI)
b-D-Glucopyranosiduronic acid,5-[(2E)-5-carboxy-3-methyl-2-penten-1-yl]-1,3-dihydro-6-methoxy-7-methyl-3-oxo-4-isobenzofuranyl
b-D-Glucopyranosiduronic acid,4-[[3-[[[4-(3-amino-3-carboxypropoxy)phenyl](formylamino)acetyl]amino]-2-oxo-1-azetidinyl]carboxymethyl]phenyl,disodium salt, [3S-[1(S*),3R*[S*(S*)]]]- (9CI)
b-D-Glucopyranosiduronic acid,(3-phenoxyphenyl)methyl
b-D-Glucopyranosiduronic acid,4-[2-hydroxy-3-(propylamino)propoxy]-3-(1-oxo-3-phenylpropyl)phenyl
b-D-Glucopyranosiduronic acid,4-[(2S,3R)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxo-2-azetidinyl]phenyl
b-D-Glucopyranosiduronic acid,[2-(2-methyl-4-oxo-3(4H)-quinazolinyl)phenyl]methyl
b-D-Glucopyranosiduronic acid,5-methyl-2-(1-methylethyl)cyclohexyl
b-D-Glucopyranosiduronic acid,2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-1-benzopyran-3-yl
b-D-Glucopyranosiduronic acid,3-carboxy-2-oxo-2H-1-benzopyran-7-yl, dipotassium salt (9CI)
b-D-Glucopyranosiduronic acid,5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-3-yl
b-D-Glucopyranosiduronic acid,5,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-3-yl
b-D-Glucopyranosiduronic acid, (3b,4b,22b)-22-[(3,4-dihydro-5-hydroxy-6-methyl-4-oxo-2H-pyran-2-yl)oxy]-23-hydroxyolean-12-en-3-ylO-b-D-glucopyranosyl-(1®2)-O-b-D-galactopyranosyl-(1®2)-
b-D-Glucopyranosiduronic acid,2-pyridinyl 1-thio-
(4R,5S,6S)-3-[[(3S,5S)-1-[(2S,3R)-2-[(2S,3R)-5-Carboxy-4-[[(3S,5S)-5-[[(3-carboxyphenyl)aMino]carbonyl]-3-pyrrolidinyl]thio]-3,4-dihydro-3-Methyl-2H-pyrrol-2-yl]-3-hydroxy-1-oxobutyl]-5-[[(3-carboxyphenyl)aMino]carbonyl]-3-pyrrolidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-Methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid
b-D-Glucopyranosiduronic acid,2-amino-3-methyl-3H-imidazo[4,5-f]quinolin-5-yl
7-chloro-5-(2-chlorophenyl)-1-methyl-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl beta-D-glucopyranosiduronic acid